Cost-Effectiveness of a Staphylococcus aureus Screening and Decolonization Program for High-Risk Orthopedic Patients

Journal of Arthroplasty

Volumn 26, Issue 3, 2011, Pages 360-365

  Slover, James ^a   Haas, Janet P ^a   Quirno, Martin ^a   Phillips, Michael S ^a   Bosco, Joseph A ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Cost effectiveness; Decolonization; High risk; Screening; Staphylococcus aureus

Indexed keywords

CEPHALOSPORIN; PSEUDOMONIC ACID; VANCOMYCIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH PROGRAM; HIGH RISK PATIENT; HIP ARTHROPLASTY; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS INFECTION; NOSE SMEAR; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; RISK REDUCTION; SCREENING TEST; SENSITIVITY ANALYSIS; SPINE FUSION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; JOINTS; MARKOV CHAINS; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; REOPERATION; RISK FACTORS; SPINAL FUSION; STAPHYLOCOCCAL INFECTIONS;

EID: 79953043014     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2010.03.009     Document Type: Article

References (19)

1. Kurtz S., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89:780.
2. Merrill C, Elixhauser A. Hospital Stays Involving Musculoskeletal Procedures, 1997-2005. Statistical Brief #34. Healthcare cost and utilization project. Agency for Healthcare Research and Quality.
3. Barnes S., et al. An enhanced benchmark for prosthetic joint replacement infection rates. Am J Infect Control 2006, 34:669.
4. Kurtz S.M., et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007, 89(Suppl 3):144.
5. Olsen M., Nepple J., Riew J., et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008, 90:62.
6. Calderone R.R., Garland D.E., Capen D.A., et al. Cost of medical care for postoperative spinal infections. Orthop Clin North Am 1996, 27:171.
7. Burns A., Bourne R. (vi) Economics of revision total hip arthroplasty. Current Orthopaedics 2006, 20:203.
8. Ridgeway S., et al. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005, 87-B:844.
9. Price C.S., Williams A., Philips G., et al. Preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008, 466:2842. [Epub ahead of print 2008 Jun 19].
10. Walls R.J., et al. Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. J Bone Joint Surg Br 2008, 90:292.
11. Kaljmeijer M.D., et al. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control and Hosp Epidemiol 2000, 21:319.
12. Kaljmeijer M.D., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002, 35:353.
13. Perl T.M., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1871.
14. Hunink M.E.A. Decision making in health and medicine 2003, Cambridge University Press.
15. Robertsson O., et al. The Swedish Knee Arthroplasty Register 1975-1997: an update with special emphasis on 41,223 knees operated on in 1988-1997. Acta Orthop Scand 2001, 72:503.
16. Slover J., et al. Cost-effectiveness of unicompartmental and total knee arthroplasty in elderly low-demand patients. A Markov decision analysis. J Bone Joint Surg Am 2006, 88:2348.
17. Bozic K.J., et al. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am 2006, 88:706.
18. Bozic K.J., Ries M.D. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005, 87:1746.
19. Graham P.L., Lin S.X., Larson E.L. A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006, 144:318.